Clinical Trial Update: Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating thoracic radiotherapy for metastatic stage IV non-small cell lung cancer at high risk of symptomatic thoracic progression is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Rochester | Conditions: Stage 4 NSCLC, Radiotherapy | Phase 2 | Status: RECRUITING